These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 24909724)

  • 21. Magnetic polycarbonate microspheres for tumor-targeted delivery of tumor necrosis factor.
    Hu B; Du HJ; Yan GP; Zhuo RX; Wu Y; Fan CL
    Drug Deliv; 2014 May; 21(3):204-12. PubMed ID: 24117028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor and immunomodulatory activity of Astragalus membranaceus polysaccharides in H22 tumor-bearing mice.
    Yang B; Xiao B; Sun T
    Int J Biol Macromol; 2013 Nov; 62():287-90. PubMed ID: 24060282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor effects and chemical compositions of Eupolyphaga sinensis Walker ethanol extract.
    Ge GF; Yu CH; Yu B; Shen ZH; Zhang DL; Wu QF
    J Ethnopharmacol; 2012 May; 141(1):178-82. PubMed ID: 22366674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrastructure of the kidney filtration barrier in conditions of distant tumor growth and lithium treatment.
    Bgatova N; Taskaeva I
    Ultrastruct Pathol; 2020 Nov; 44(4-6):412-421. PubMed ID: 33251931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-cancer mechanisms of clinically acceptable colchicine concentrations on hepatocellular carcinoma.
    Lin ZY; Wu CC; Chuang YH; Chuang WL
    Life Sci; 2013 Sep; 93(8):323-8. PubMed ID: 23871804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival after gamma interferon intratumoral injections in a model of hepatocarcinoma.
    Peyrègne V; Quash G; Isaac S; Chantepie J; Akiba H; Scoazec JY; Gilly FN
    Hepatogastroenterology; 2004; 51(58):1115-20. PubMed ID: 15239257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-hepatoma activity and mechanism of corn silk polysaccharides in H22 tumor-bearing mice.
    Yang J; Li X; Xue Y; Wang N; Liu W
    Int J Biol Macromol; 2014 Mar; 64():276-80. PubMed ID: 24315949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lithium effects on vesicular trafficking in hepatocellular carcinoma cells.
    Taskaeva I; Bgatova N; Gogaeva I
    Ultrastruct Pathol; 2019; 43(6):301-311. PubMed ID: 31826700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vigilin is overexpressed in hepatocellular carcinoma and is required for HCC cell proliferation and tumor growth.
    Yang WL; Wei L; Huang WQ; Li R; Shen WY; Liu JY; Xu JM; Li B; Qin Y
    Oncol Rep; 2014 May; 31(5):2328-34. PubMed ID: 24676454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Foretinib demonstrates anti-tumor activity and improves overall survival in preclinical models of hepatocellular carcinoma.
    Huynh H; Ong R; Soo KC
    Angiogenesis; 2012 Mar; 15(1):59-70. PubMed ID: 22187171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of lithium carbonate administration to healthy cats.
    Dieringer TM; Brown SA; Rogers KS; Lees GE; Whitney MS; Weeks BR
    Am J Vet Res; 1992 May; 53(5):721-6. PubMed ID: 1524296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of lithium carbonate on monocyte to macrophage maturation in cancer patients.
    Visca U; Giulivi A; Ventura M; Spina M; Massari A; Pomo A; Santi G
    Boll Ist Sieroter Milan; 1984 May; 63(2):154-9. PubMed ID: 6432004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.
    Zheng L; Yang W; Wu F; Wang C; Yu L; Tang L; Qiu B; Li Y; Guo L; Wu M; Feng G; Zou D; Wang H
    Clin Cancer Res; 2013 Oct; 19(19):5372-80. PubMed ID: 23942093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel human tumor necrosis factor alfa mutein, F4614, inhibits in vitro and in vivo growth of murine and human hepatoma: implication for immunotherapy of human hepatocellular carcinoma.
    Atarashi Y; Yasumura S; Nambu S; Yoshio Y; Murakami J; Takahara T; Higuchi K; Watanabe A; Miyata K; Kato M
    Hepatology; 1998 Jul; 28(1):57-67. PubMed ID: 9657097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-inhibitory effect and immunomodulatory activity of fullerol C60(OH)x.
    Zhu J; Ji Z; Wang J; Sun R; Zhang X; Gao Y; Sun H; Liu Y; Wang Z; Li A; Ma J; Wang T; Jia G; Gu Y
    Small; 2008 Aug; 4(8):1168-75. PubMed ID: 18574800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sprengerinin C exerts anti-tumorigenic effects in hepatocellular carcinoma via inhibition of proliferation and angiogenesis and induction of apoptosis.
    Zeng KW; Li N; Dong X; Ma ZZ; Jiang Y; Jin HW; Tu PF
    Eur J Pharmacol; 2013 Aug; 714(1-3):261-73. PubMed ID: 23684542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of sirolimus on the growth of transplanted hepatocellular carcinoma].
    Zhang J; Li H; Wang GS; Jiang N; Yang Y; Chen GH
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):413-6. PubMed ID: 19567017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone marrow cells: Important role on neovascularization of hepatocellular carcinoma.
    Zhu H; Shao Q; Sun X; Deng Z; Yuan X; Zhou X; Ding Y
    J Gastroenterol Hepatol; 2012 Jul; 27(7):1241-51. PubMed ID: 22142567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway.
    Jung KH; Choi MJ; Hong S; Lee H; Hong SW; Zheng HM; Lee HS; Hong S; Hong SS
    Cancer Lett; 2012 Mar; 316(2):187-95. PubMed ID: 22182943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of different tumor response criteria in patients with hepatocellular carcinoma after systemic therapy with the multikinase inhibitor sorafenib.
    Spira D; Fenchel M; Lauer UM; Claussen CD; Gregor M; Bitzer M; Horger M
    Acad Radiol; 2011 Jan; 18(1):89-96. PubMed ID: 20926315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.